These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8631960

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents.
    Kulmacz RJ, Lands WE.
    J Biol Chem; 1985 Oct 15; 260(23):12572-8. PubMed ID: 3930499
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret JP, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman S, Léger S, Mancini JA, O'Neill G, Ouellet M, Rodger IW, Thérien M, Wang Z, Webb JK, Wong E, Chan CC.
    Br J Pharmacol; 1997 May 15; 121(1):105-17. PubMed ID: 9146894
    [Abstract] [Full Text] [Related]

  • 6. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
    Greig GM, Francis DA, Falgueyret JP, Ouellet M, Percival MD, Roy P, Bayly C, Mancini JA, O'Neill GP.
    Mol Pharmacol; 1997 Nov 15; 52(5):829-38. PubMed ID: 9351974
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of satigrel (E5510), a new anti-platelet drug, in inhibiting human platelet aggregation. Selectivity and potency against prostaglandin H synthases isozyme activities and phosphodiesterase isoform activities.
    Nagakura N, Saeki T, Harada K, Yoshitake S, Kobayashi S, Yamanaka T, Saito I.
    Biol Pharm Bull; 1996 Jun 15; 19(6):828-33. PubMed ID: 8799481
    [Abstract] [Full Text] [Related]

  • 8. Inhibitor-induced changes in the intrinsic fluorescence of human cyclooxygenase-2.
    Houtzager V, Ouellet M, Falgueyret JP, Passmore LA, Bayly C, Percival MD.
    Biochemistry; 1996 Aug 20; 35(33):10974-84. PubMed ID: 8718891
    [Abstract] [Full Text] [Related]

  • 9. The structural and electronical factors that contribute affinity for the time-dependent inhibition of PGHS-1 by indomethacin, diclofenac and fenamates.
    Pouplana R, Pérez C, Sánchez J, Lozano JJ, Puig-Parellada P.
    J Comput Aided Mol Des; 1999 May 20; 13(3):297-313. PubMed ID: 10216835
    [Abstract] [Full Text] [Related]

  • 10. The dynamics of prostaglandin H synthases. Studies with prostaglandin h synthase 2 Y355F unmask mechanisms of time-dependent inhibition and allosteric activation.
    So OY, Scarafia LE, Mak AY, Callan OH, Swinney DC.
    J Biol Chem; 1998 Mar 06; 273(10):5801-7. PubMed ID: 9488715
    [Abstract] [Full Text] [Related]

  • 11. Slow-binding inhibition of human prostaglandin endoperoxide synthase-2 with darbufelone, an isoform-selective antiinflammatory di-tert-butyl phenol.
    Johnson AR, Marletta MA, Dyer RD.
    Biochemistry; 2001 Jun 26; 40(25):7736-45. PubMed ID: 11412128
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Peroxidase self-inactivation in prostaglandin H synthase-1 pretreated with cyclooxygenase inhibitors or substituted with mangano protoporphyrin IX.
    Wu G, Vuletich JL, Kulmacz RJ, Osawa Y, Tsai AL.
    J Biol Chem; 2001 Jun 08; 276(23):19879-88. PubMed ID: 11279106
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of flurbiprofen and flurbinitroxybutylester on prostaglandin endoperoxide synthases.
    Santini G, Sciulli MG, Panara MR, Padovano R, di Giamberardino M, Rotondo MT, Del Soldato P, Patrignani P.
    Eur J Pharmacol; 1996 Nov 28; 316(1):65-72. PubMed ID: 8982652
    [Abstract] [Full Text] [Related]

  • 16. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.
    Laneuville O, Breuer DK, Dewitt DL, Hla T, Funk CD, Smith WL.
    J Pharmacol Exp Ther; 1994 Nov 28; 271(2):927-34. PubMed ID: 7965814
    [Abstract] [Full Text] [Related]

  • 17. Molecular modelling of the differential interaction between several non-steroidal anti-inflammatory drugs and human prostaglandin endoperoxide H synthase-2 (h-PGHS-2).
    Pouplana R, Lozano JJ, Ruiz J.
    J Mol Graph Model; 2002 Jan 28; 20(4):329-43. PubMed ID: 11858641
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.